Dr Rishi Puri shares an expert point of view on the trajectory of the TAVI field over the next five to ten years. The discussion addresses the key clinical considerations when selecting a valve for younger patient populations and offers guidance on how to interpret recent long-term durability data from low-risk trials. Dr Rishi Puri also explores the fundamental impact of valve design on long-term patient outcomes, concluding with a look at the essential characteristics that define an ideal valve for lifetime patient management.